Compared to HD, in MM patients, the ILC2s of PB expressed a lower level of the DNAM-1 receptor but a considerable level of GZMB, enabling them to kill MM cells (Figure 2B,C,G). The gene discussed is GZMB; the disease is Miyoshi myopathy.